Considered genotoxic by weight of evidence; labeled with a genotoxicity Warning
“Based on the weight of evidence from these studies, nifurtimox is considered to be genotoxic and the product label for Lampit will include a Warning for genotoxicity.”
✓ VerifiedFDA multi-discipline review, p. 44Source ↗
Carcinogenicity
Not required (treatment duration under 6 months)
“Because the proposed treatment duration of nifurtimox is less than 6 months, a carcinogenicity assessment is not required.”
✓ VerifiedFDA multi-discipline review, p. 44Source ↗
Instead of carcinogenicity
Not stated in public reviews
Not reported in the public reviews. Reviewers summarise selectively, so this usually means it wasn't discussed publicly, not that it wasn't studied.
Instead of genotoxicity
Not stated in public reviews
Not reported in the public reviews. Reviewers summarise selectively, so this usually means it wasn't discussed publicly, not that it wasn't studied.
DRG histopathology
Not stated in public reviews
Not reported in the public reviews. Reviewers summarise selectively, so this usually means it wasn't discussed publicly, not that it wasn't studied.
Reproductive & developmental
Mouse, rat and rabbit EFD: maternal and/or fetal toxicity in all species; fetal malformation in rabbits
“In preliminary embryo-fetal studies in rats and mice and a comprehensive study in rabbits, nifurtimox produced dose-related maternal and/or fetal toxicity in all test species as well as a fetal malformation in rabbits.”
✓ VerifiedFDA multi-discipline review, p. 47Source ↗
Safety pharmacology
hERG IC50 98 µM (28.2 µg/mL); slight QTc increase at 80 mg/kg in telemetered dogs
“Nifurtimox at high concentrations was shown to inhibit hERG channels with an estimated IC50 value of 98 mcM (28.2 mcg/ml). In a cardiovascular study in conscious telemetered dogs, QTc intervals were slightly increased at a nifurtimox dose of 80 mg/kg.”
✓ VerifiedFDA multi-discipline review, p. 43Source ↗
Genotox: Ames
Positive: dose-dependent mutant increases with and without S9
“In Ames assays, nifurtimox produced dose-dependent increases in the number of mutants with and without S9 activation, and, in an in vitro micronucleus assay, nifurtimox was clastogenic in human lymphocytes.”
✓ VerifiedFDA multi-discipline review, p. 44Source ↗
Genotox: in vitro mammalian
Positive: in vitro micronucleus, clastogenic in human lymphocytes
“In Ames assays, nifurtimox produced dose-dependent increases in the number of mutants with and without S9 activation, and, in an in vitro micronucleus assay, nifurtimox was clastogenic in human lymphocytes.”
✓ VerifiedFDA multi-discipline review, p. 44Source ↗
Genotox: in vivo
Positive: mouse micronucleus and mouse sister chromatid exchange; chromosome aberrations in Chagas patients
“In vivo, nifurtimox was shown to be positive for clastogenesis in a mouse micronucleus assay, a mouse sister chromatid exchange assay, and a chromosome aberration assay in Chagas patients.”
✓ VerifiedFDA multi-discipline review, p. 44Source ↗
Carcinogenicity model
Not required (treatment under 6 months); deficient literature studies in mice and rats submitted
“Because the proposed treatment duration of nifurtimox is less than 6 months, a carcinogenicity assessment is not required. However, three carcinogenicity studies for nifurtimox were submitted in NDA 213464, two in limited brief study reports and one in a published manuscript.”
✓ VerifiedFDA multi-discipline review, p. 44Source ↗
Carcinogenicity timing
Not required: treatment duration under 6 months
“Because the proposed treatment duration of nifurtimox is less than 6 months, a carcinogenicity assessment is not required.”
✓ VerifiedFDA multi-discipline review, p. 44Source ↗
hERG / QT
hERG IC50 28.2 mcg/mL, ~38-fold the clinical Cmax
“The 28.2 mcg/ml IC50 value for nifurtimox inhibition of hERG channels is approximately 38-fold higher than the clinical Cmax value of 751 ng/ml measured in healthy human subjects administered a single dose of 15 mg/kg nifurtimox (Paulos et al. 1989).”
✓ VerifiedFDA multi-discipline review, p. 48Source ↗
Not genotoxic overall: Ames negative; in vitro chromosome aberration positive without (not with) metabolic activation; rat micronucleus and comet negative